Expanding Product Portfolio Bausch + Lomb has recently launched advanced intraocular lenses such as enVista Aspire monofocal and toric IOLs, indicating a focus on innovative surgical solutions. Exploring complementary surgical devices or advanced diagnostic tools could present additional sales opportunities.

Strategic Market Growth The company's acquisition of Trukera Medical and active participation in global events like the SFO Congress highlight expansion efforts in the US surgical and dry eye markets. Targeting specialized devices and dry eye treatment products may align with their growth trajectory.

Strong Industry Presence Operating in over 100 countries with a comprehensive product portfolio positions Bausch + Lomb as a key player in eye health. Offering localized or custom solutions tailored to regional market needs could enhance market penetration.

Focus on Eye Care Innovation Initiatives such as the Faces of Glaucoma campaign and new product launches demonstrate a commitment to raising awareness and advancing treatment options. Partnering on educational or innovative patient care technologies could open new sales channels.

Technological Investment Utilizing a sophisticated tech stack including SAP Cloud and JSON-LD, Bausch + Lomb emphasizes digital capabilities. Providing digital health solutions, data management tools, or telemedicine integrations could be valuable opportunities for collaboration.